|
CZ40998A3
(cs)
*
|
1995-08-14 |
1998-09-16 |
The Scripps Research Institute |
Použití antagonisty anb5 pro výrobu prostředků, schopných inhibovat angiogenezi v tkáních
|
|
US7053041B1
(en)
*
|
1996-05-31 |
2006-05-30 |
The Scripps Research Institute |
Methods and compositions useful for inhibition of αvβ5mediated angiogenesis
|
|
US20040063790A1
(en)
*
|
1996-05-31 |
2004-04-01 |
The Scripps Research Institute |
Methods for inhibition of angiogenesis
|
|
US20050281821A1
(en)
*
|
1999-01-06 |
2005-12-22 |
Flavia Pernasetti |
Method and composition for angiogenesis inhibition
|
|
EP1260538B1
(en)
*
|
1999-10-06 |
2010-12-01 |
Kaneka Corporation |
Process for producing polyimide resin
|
|
US7122318B2
(en)
*
|
2001-02-21 |
2006-10-17 |
Eisai Co., Ltd. |
Method for testing effect of angiogenesis inhibitor via integrin expression inhibition
|
|
US7019108B2
(en)
*
|
2001-06-01 |
2006-03-28 |
University Of Southern California |
Method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2
|
|
AU2002319282B2
(en)
*
|
2001-08-01 |
2007-06-28 |
Merck Patent Gmbh |
Integrin inhibitors for the treatment of eye diseases
|
|
US7301006B2
(en)
*
|
2002-07-16 |
2007-11-27 |
Wisconsin Alumni Research Foundation |
Methods and materials for the synthesis of modified peptides
|
|
FR2856598B1
(fr)
*
|
2003-06-25 |
2005-10-28 |
Inst Nat Sante Rech Med |
Peptides derives de la proteine mmp-2 et leur utilisation en immunotherapie antitumorale
|
|
WO2005090406A2
(en)
|
2004-03-12 |
2005-09-29 |
Vasgene Therapeutics, Inc. |
Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth
|
|
RU2361614C2
(ru)
*
|
2004-03-24 |
2009-07-20 |
ПиДиЭл БАЙОФАРМА, ИНК. |
ПРИМЕНЕНИЕ АНТИТЕЛ ПРОТИВ α5β1 ДЛЯ ИНГИБИРОВАНИЯ ПРОЛИФЕРАЦИИ РАКОВЫХ КЛЕТОК
|
|
WO2005117968A2
(en)
*
|
2004-04-14 |
2005-12-15 |
Genentech, Inc. |
Compositions and methods comprising an egfl7 antagonist for modulating vascular development
|
|
US7973134B2
(en)
*
|
2004-07-07 |
2011-07-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways
|
|
WO2006034455A2
(en)
|
2004-09-23 |
2006-03-30 |
Vasgene Therapeutics, Inc. |
Polipeptide compounds for inhibiting angiogenesis and tumor growth
|
|
US7935790B2
(en)
*
|
2004-10-04 |
2011-05-03 |
Cell Singaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways
|
|
US7807789B2
(en)
*
|
2004-12-21 |
2010-10-05 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
|
|
CN101098887B
(zh)
*
|
2005-01-03 |
2011-05-04 |
弗·哈夫曼-拉罗切有限公司 |
作为多肽支架的血红素结合蛋白样结构
|
|
EP1902725B1
(en)
*
|
2005-02-24 |
2014-03-26 |
The Scripps Research Institute |
Revascularization of ischemic retinal tissue
|
|
US20090099340A1
(en)
*
|
2007-10-12 |
2009-04-16 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
US20060286148A1
(en)
*
|
2005-05-18 |
2006-12-21 |
Ppd, Inc. |
Method of forming implants
|
|
AU2006283174A1
(en)
*
|
2005-08-24 |
2007-03-01 |
Cell-Matrix, Inc. |
Combination therapies for inhibiting integrin-extracellular matrix interactions
|
|
US20100151495A9
(en)
*
|
2005-08-31 |
2010-06-17 |
Cell Signaling Technolgy, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
EP1934867A2
(en)
*
|
2005-08-31 |
2008-06-25 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
|
|
US20080289578A1
(en)
*
|
2005-09-20 |
2008-11-27 |
Rybarczyk Jr Phillip L |
Methods for Rapidly and Accurately Locating Avian Egg Blastoderms
|
|
NZ594285A
(en)
*
|
2005-11-04 |
2013-02-22 |
Genentech Inc |
USE OF COMPLEMENT PATHWAY INHIBITOR ANTIBODY AGAINST C5a TO TREAT OCULAR DISEASES
|
|
NZ599035A
(en)
|
2006-01-12 |
2013-12-20 |
Alexion Pharma Inc |
Antibodies to ox-2/cd200 and uses thereof
|
|
CA2638040A1
(en)
*
|
2006-02-09 |
2007-08-16 |
Micromet Ag |
Treatment of metastatic breast cancer
|
|
WO2007127335A2
(en)
*
|
2006-04-27 |
2007-11-08 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in atm and atr kinase signaling pathways
|
|
EP1862541A1
(en)
*
|
2006-06-01 |
2007-12-05 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Polypeptides derived from the hemopexin-like domain of metalloproteinase MMP-2
|
|
US7939636B2
(en)
*
|
2006-08-11 |
2011-05-10 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in c-Src signaling pathways
|
|
US20090258442A1
(en)
*
|
2006-08-31 |
2009-10-15 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
JP5237970B2
(ja)
|
2007-02-01 |
2013-07-17 |
アクセルロン ファーマ， インコーポレイテッド |
乳癌を治療または予防するためのアクチビンＡｃｔＲＩＩａアンタゴニストおよび使用
|
|
US20090081659A1
(en)
|
2007-03-07 |
2009-03-26 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
|
|
EP1975184A3
(en)
|
2007-03-26 |
2008-11-26 |
Cell Signaling Technology, Inc. |
Serine or threonine phosphorylation sites
|
|
US20080238709A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Faramarz Vaziri |
One-way communication apparatus with dynamic key generation
|
|
EP1983003A3
(en)
|
2007-04-19 |
2009-03-11 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
|
EP2145902A3
(en)
|
2007-04-19 |
2010-09-29 |
Peter Hornbeck |
Tyrosine phosphorylation sites and antibodies specific for them
|
|
US7977462B2
(en)
|
2007-04-19 |
2011-07-12 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
|
US20090053831A1
(en)
|
2007-05-01 |
2009-02-26 |
Cell Signaling Technology, Inc. |
Tyrosine phosphorylation sites
|
|
US7960343B2
(en)
|
2007-09-18 |
2011-06-14 |
Acceleron Pharma Inc. |
Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretion
|
|
US20090203043A1
(en)
|
2007-11-21 |
2009-08-13 |
Peter Hornbeck |
Protein phosphorylation by basophilic serine/threonine kinases in insulin signaling pathways
|
|
US20090220991A1
(en)
*
|
2008-02-29 |
2009-09-03 |
Cell Signaling Technology, Inc. |
Reagents for the detection of protein phosphorylation in leukemia signaling pathways
|
|
US11673914B2
(en)
|
2009-11-10 |
2023-06-13 |
Allegro Pharmaceuticals, LLC |
Peptide therapies for reduction of macular thickening
|
|
BR112012011731A2
(pt)
|
2009-11-10 |
2020-08-25 |
Allegro Pharmaceuticals, Inc. |
composições e métodos para inibir a adesão celular ou direcionamento dos agentes de diagnóstico ou terapêuticos para os sítios de ligação rgd
|
|
RU2429836C1
(ru)
*
|
2010-04-01 |
2011-09-27 |
Максуд Мухамеджанович Расулов |
СРЕДСТВО, СТИМУЛИРУЮЩЕЕ ЭКСПРЕССИЮ МАТРИЧНОЙ РНК ТРИПТОФАНИЛ-тРНК-СИНТЕТАЗЫ
|
|
PH12013500577B1
(en)
*
|
2010-10-07 |
2019-06-28 |
Aerpio Therapeutics Inc |
Compositions and methods for treating ocular edema, neovascularization and related diseases
|
|
KR102165421B1
(ko)
|
2011-05-09 |
2020-10-14 |
알레그로 파마슈티칼스, 인코포레이티드. |
인테그린 수용체 길항물질 및 이의 사용 방법
|
|
HK1206610A1
(en)
|
2012-03-30 |
2016-01-15 |
Sorrento Therapeutics, Inc. |
Fully human antibodies that bind to vegfr2
|
|
EP3515495A4
(en)
|
2016-09-26 |
2020-08-26 |
Ensemble Group Holdings |
CANCER ASSESSMENT AND TREATMENT PROCEDURES IN SUBJECTS WITH DYSREGULATED LYMPHATIC SYSTEMS
|
|
JP2020512978A
(ja)
*
|
2017-03-31 |
2020-04-30 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
アルファ−Ｖ ベータ−３（αｖβ３）陽性がん幹細胞（ＣＳＣＳ）を処置および殺滅するためならびに薬物耐性がんを処置するための組成物および方法
|
|
CN113663929A
(zh)
*
|
2021-09-24 |
2021-11-19 |
深圳市广利达精密机械有限公司 |
一种自动化机械加工零件自动加工分拣设备及其方法
|